← Back to Patent Explorer
US4259202A Expired / Lapsed US ⏱️ 0.0 years remaining

Cleaning and preservative solution for contact lenses

Assignee: Menicon Co Ltd
•
Filing: 1979-06-04
•
Granted: 1981-03-31
•
Expires: 1999-06-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A cleaning and preservative solution for contact lenses which contains as an effective ingredient a monoester of saccharose with a fatty acid having the general formula: ##STR1## wherein R is a saturated or unsaturated aliphatic hydrocarbon group having 8 to 18 carbon atoms. The solution has excellent cleaning and preservative effects. Contact lenses can be cleaned during the preservation of the lenses with soaking them in the solution.

Inventors

  • 👤 Kyoichi Tanaka
  • 👤 Akira Tsuzuki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 04:25
CPC Classifications
C; C11; C11D; C11D3/00; C11D3/0005; C11D3/0078; A; A61; A61L; A61L12/00; A61L12/08; A61L12/14; C11D1/00; C11D1/66; C11D1/667; C11D1/662

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 108 words
A cleaning and preservative solution for contact lenses comprised of: as an effective ingredient a monoester of saccharose in a concentration of 0.01 to 0.5 w/v %, a compound selected from the group consisting of a polysaccharide and a polysaccharide derivative, in a concentration of 0.01 to 10 w/v %: said monoester being a saccharose fatty ester having the following general formula: ##STR3## wherein R is a saturated or unsaturated aliphatic hydrocarbon group having 8 to 18 carbon atoms; and an alkali metal salt of a saturated fatty acid in a concentration of 0.001 to 1 w/v % having an alkyl group of 7 to 18 carbon atoms.
Claim 2
Dependent Claim 108 words
A cleaning and preservative solution for contact lenses comprised of: as an effective ingredient a monoester of saccharose in a concentration of 0.01 to 0.5 w/v %, a compound selected from the group consisting of a polysaccharide and a polysaccharide derivative, in a concentration of 0.01 to 10 w/v %: said monoester being a saccharose fatty ester having the following general formula: ##STR3## wherein R is a saturated or unsaturated aliphatic hydrocarbon group having 8 to 18 carbon atoms; and an alkali metal salt of a saturated fatty acid in a concentration of 0.001 to 1 w/v % having an alkyl group of 7 to 18 carbon atoms.
Claim 3
Dependent Claim 52 words
The cleaning and preservative solution of claim 1, in which the monoester of saccharose is at least one member selected from the group consisting of saccharose monodecylate, saccharose monoundecylate, saccharose monolaurate, saccharose monotridecylate, saccharose monomyristate, saccharose monononanate, saccharose monopentadecylate, saccharose monopalmitate, saccharose monoheptadecylate, saccharose monostearate, saccharose monooleate, saccharose monolinoleate amd saccharose monolinolenate.
Claim 4
Dependent Claim 84 words
The cleaning and preservative solution of claim 1, in which the polysaccharide or its derivative is at least one member selected from the group consisting of alkali metal salt of alginic acid, alkali metal salt of pectic acid, pectic acid derivative, dextran, xanthan gum, tragacanth gum, agar, locust bean gum, guar gum, methyl cellulose, alkali metal salt of carboxymethyl cellulose, alkali metal salt of carboxyethyl cellulose, methyl propyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose and alkali metal salt of chondroitin sulfuric acid.
Claim 5
Dependent Claim 25 words
The cleaning and preservative solution of claim 1, which further contains an ophthalmology-physiologically acceptable buffer in a concentration of about 0.01 to about 1 mole/liter.
Claim 6
Dependent Claim 24 words
The cleaning and preservative solution of claim 1, which further contains an ophthalmology-physiologically acceptable bactericide in a concentration of 0.0001 to 0.5 w/v %.
Claim 7
Dependent Claim 38 words
The cleaning and preservative solution of claim 1, which further contains an ophthalmology-physiologically acceptable buffer in a concentration of about 0.01 to 1 mole/liter and an ophthalmology-physiologically acceptable bactericide in a concentration of 0.0001 to 0.5 w/v %.

References Cited (Backward Citations)

US2893990A Cited
US2999858A Cited
US3141013A Cited
US3882036A Cited
US3954644A Cited
US3702364A Cited
US3872020A Cited
US3884826A Cited
US4013576A Cited
US4046706A Cited
US4104187A Cited
US4127423A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-03-30 1984-09-29 1985-03-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-03-30 1988-09-29 1989-03-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-03-30 1992-09-29 1993-03-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag